Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Human Gene Therapy
|
August 17, 2001
Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo
A Bartholomew, S Patil, A Mackay, et al.
Inflammatory Bowel Diseases
|
July 17, 2015
Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease
Patricia L Pringle, Kathleen O Stewart, Joanna M Peloquin, et al.
Digestive Diseases and Sciences
|
February 22, 2015
High C-Reactive Protein Is Associated with Poor Sleep Quality Independent of Nocturnal Symptoms in Patients with Inflammatory Bowel Disease
Robin G Wilson, Betsy W Stevens, Abra Y Guo, et al.
Anticancer Research
|
September 2, 1999
Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients
A van Dalen, J Favier, L Baumgartner, et al.
Experimental Hematology
|
February 13, 2001
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion
S M Devine, A M Bartholomew, N Mahmud, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
September 27, 2013
Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop
P Berger, E Paus, P M Hemken, et al.
BMC Gastroenterology
|
December 17, 2014
Early life environment and natural history of inflammatory bowel diseases
Abra Y Guo, Betsy W Stevens, Robin G Wilson, et al.
Anticancer Research
|
May 1, 2001
Serum levels of CA 125 and TPS during treatment of ovarian cancer
A Van Dalen, J Favier, L Baumgartner, et al.
European Journal of Gynaecological Oncology
|
January 27, 2010
Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up
A van Dalen, J Favier, E Hallensleben, et al.
Gynecologic Oncology
|
December 6, 2000
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients
A van Dalen, J Favier, A Burges, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Human Gene Therapy
|
August 17, 2001
Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo
A Bartholomew, S Patil, A Mackay, et al.
Inflammatory Bowel Diseases
|
July 17, 2015
Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease
Patricia L Pringle, Kathleen O Stewart, Joanna M Peloquin, et al.
Digestive Diseases and Sciences
|
February 22, 2015
High C-Reactive Protein Is Associated with Poor Sleep Quality Independent of Nocturnal Symptoms in Patients with Inflammatory Bowel Disease
Robin G Wilson, Betsy W Stevens, Abra Y Guo, et al.
Anticancer Research
|
September 2, 1999
Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients
A van Dalen, J Favier, L Baumgartner, et al.
Experimental Hematology
|
February 13, 2001
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion
S M Devine, A M Bartholomew, N Mahmud, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
September 27, 2013
Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop
P Berger, E Paus, P M Hemken, et al.
BMC Gastroenterology
|
December 17, 2014
Early life environment and natural history of inflammatory bowel diseases
Abra Y Guo, Betsy W Stevens, Robin G Wilson, et al.
Anticancer Research
|
May 1, 2001
Serum levels of CA 125 and TPS during treatment of ovarian cancer
A Van Dalen, J Favier, L Baumgartner, et al.
European Journal of Gynaecological Oncology
|
January 27, 2010
Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up
A van Dalen, J Favier, E Hallensleben, et al.
Gynecologic Oncology
|
December 6, 2000
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients
A van Dalen, J Favier, A Burges, et al.
Page
of 5